REPORTS

Let’s Pullulate and Expand Your Business

Monoclonal Antibody Based Products Market - Global Professional Analysis and Forecast to 2026

Oct 23, 2019  |  199 PAGES  |  REPORT CODE: CMM221955
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Monoclonal Antibody Based Products market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 9.5% during the forecast period.

This report presents the market size and development trends by detailing the Monoclonal Antibody Based Products market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Monoclonal Antibody Based Products market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Monoclonal Antibody Based Products industry and will help you to build a panoramic view of the industrial development.

Monoclonal Antibody Based Products Market, By Type:

  • Murine

  • Chimeric

  • Humanized

  • Human

Monoclonal Antibody Based Products Market, By Application:

  • Therapeutics

  • Diagnostics

Some of the leading players are as follows:

  • BD Biosciences

  • CMC ICOS Biologics, Inc.

  • Human Genome Sciences, Inc.

  • PDL BioPharma

  • Strategic Diagnostics Inc

  • Amgen, Inc.

  • Dendreon Corporation

  • Biogen Idec Inc

  • Wyeth Pharmaceuticals

  • Schering-Plough Corporation

  • Medarex, Inc.

  • UCB Group

  • Johnson & Johnson

  • Immunomedics, Inc.

  • Eli Lilly and Company

  • MedImmune, Inc.

  • Genentech, Inc.

  • Elan Corporations Plc

  • Biotest AG

  • Centocor

  • Ortho Biotech Products, L.P.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Monoclonal Antibody Based Products Market: Technology Type Analysis

  • 4.1 Monoclonal Antibody Based Products Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Monoclonal Antibody Based Products Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Murine

    • 4.3.2 Chimeric

    • 4.3.3 Humanized

    • 4.3.4 Human

5 Monoclonal Antibody Based Products Market: Product Analysis

  • 5.1 Monoclonal Antibody Based Products Product Market Share Analysis, 2018 & 2026

  • 5.2 Monoclonal Antibody Based Products Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Monoclonal Antibody Based Products Market: Application Analysis

  • 6.1 Monoclonal Antibody Based Products Application Market Share Analysis, 2018 & 2026

  • 6.2 Monoclonal Antibody Based Products Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Therapeutics

    • 6.3.2 Diagnostics

7 Monoclonal Antibody Based Products Market: Regional Analysis

  • 7.1 Monoclonal Antibody Based Products Regional Market Share Analysis, 2018 & 2026

  • 7.2 Monoclonal Antibody Based Products Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 BD Biosciences

    • 9.1.1 BD Biosciences Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 CMC ICOS Biologics, Inc.

    • 9.2.1 CMC ICOS Biologics, Inc. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Human Genome Sciences, Inc.

    • 9.3.1 Human Genome Sciences, Inc. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 PDL BioPharma

    • 9.4.1 PDL BioPharma Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Strategic Diagnostics Inc

    • 9.5.1 Strategic Diagnostics Inc Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Amgen, Inc.

    • 9.6.1 Amgen, Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Dendreon Corporation

    • 9.7.1 Dendreon Corporation Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Biogen Idec Inc

    • 9.8.1 Biogen Idec Inc Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Wyeth Pharmaceuticals

    • 9.9.1 Wyeth Pharmaceuticals Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Schering-Plough Corporation

    • 9.10.1 Schering-Plough Corporation Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Medarex, Inc.

    • 9.11.1 Medarex, Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 UCB Group

    • 9.12.1 UCB Group Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Johnson & Johnson

    • 9.13.1 Johnson & Johnson Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Immunomedics, Inc.

    • 9.14.1 Immunomedics, Inc. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Eli Lilly and Company

    • 9.15.1 Eli Lilly and Company Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 MedImmune, Inc.

    • 9.16.1 MedImmune, Inc. Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Genentech, Inc.

    • 9.17.1 Genentech, Inc. Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Elan Corporations Plc

    • 9.18.1 Elan Corporations Plc Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Biotest AG

    • 9.19.1 Biotest AG Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Centocor

    • 9.20.1 Centocor Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Ortho Biotech Products, L.P.

    • 9.21.1 Ortho Biotech Products, L.P. Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

 

The List of Tables and Figures (Totals 103 Figures and 151 Tables)

  • Figure Murine Monoclonal Antibody Based Products market, 2015 - 2026 (USD Million)

  • Figure Chimeric Monoclonal Antibody Based Products market, 2015 - 2026 (USD Million)

  • Figure Humanized Monoclonal Antibody Based Products market, 2015 - 2026 (USD Million)

  • Figure Human Monoclonal Antibody Based Products market, 2015 - 2026 (USD Million)

  • Figure Therapeutics market, 2015 - 2026 (USD Million)

  • Figure Diagnostics market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Monoclonal Antibody Based Products market, by country, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table North America Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Canada Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Canada Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibody Based Products market, by country, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Europe Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Germany Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Germany Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table France Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table France Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Italy Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Italy Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Spain Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Spain Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibody Based Products market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table China Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table China Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Japan Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Japan Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table India Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table India Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibody Based Products market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibody Based Products market, by country, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table MEA Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Monoclonal Antibody Based Products market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Monoclonal Antibody Based Products market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Monoclonal Antibody Based Products market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table BD Biosciences Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CMC ICOS Biologics, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Human Genome Sciences, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PDL BioPharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Strategic Diagnostics Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Amgen, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Dendreon Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biogen Idec Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Wyeth Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Schering-Plough Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medarex, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table UCB Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Immunomedics, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MedImmune, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Genentech, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Elan Corporations Plc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biotest AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Centocor Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ortho Biotech Products, L.P. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top